354 related articles for article (PubMed ID: 7931159)
21. Differences in EBNA2 and LMP-1 carboxy terminal region sequences of Epstein-Barr virus type A between the tumors in a multiple cancer patient.
Higa M; Kinjo T; Miyagi J; Sakumoto N; Iwamasa T; Kishaba M; Sunakawa H
Pathol Res Pract; 2001; 197(6):401-9. PubMed ID: 11432667
[TBL] [Abstract][Full Text] [Related]
22. Analyses of Epstein-Barr virus latent membrane protein-1 in Malaysian nasopharyngeal carcinoma: high prevalence of 30-bp deletion, Xho1 polymorphism and evidence of dual infections.
Tan EL; Peh SC; Sam CK
J Med Virol; 2003 Feb; 69(2):251-7. PubMed ID: 12683415
[TBL] [Abstract][Full Text] [Related]
23. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.
Hu LF; Zabarovsky ER; Chen F; Cao SL; Ernberg I; Klein G; Winberg G
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2399-409. PubMed ID: 1681026
[TBL] [Abstract][Full Text] [Related]
24. High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients.
Dardari R; Khyatti M; Cordeiro P; Odda M; ElGueddari B; Hassar M; Menezes J
Int J Cancer; 2006 Apr; 118(8):1977-83. PubMed ID: 16287066
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.
Fielding CA; Sandvej K; Mehl A; Brennan P; Jones M; Rowe M
J Virol; 2001 Oct; 75(19):9129-41. PubMed ID: 11533177
[TBL] [Abstract][Full Text] [Related]
26. [Sequence analysis of the carboxy terminal of the Epstein-Barr virus LMP-1 oncogene in Epstein-Barr virus associated disorders].
Itakura O; Kikuta H
Nihon Rinsho; 1997 Feb; 55(2):467-72. PubMed ID: 9046842
[TBL] [Abstract][Full Text] [Related]
27. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
[TBL] [Abstract][Full Text] [Related]
28. Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from Eastern China and Japan.
Wang Y; Kanai K; Satoh Y; Luo B; Sairenji T
Intervirology; 2007; 50(3):229-36. PubMed ID: 17356301
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
30. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.
Cheung ST; Leung SF; Lo KW; Chiu KW; Tam JS; Fok TF; Johnson PJ; Lee JC; Huang DP
Int J Cancer; 1998 May; 76(3):399-406. PubMed ID: 9579578
[TBL] [Abstract][Full Text] [Related]
31. Nasopharyngeal carcinoma in Indonesia has a low prevalence of the 30-base pair deletion of Epstein-Barr virus latent membrane protein 1.
Nurhantari Y; Emoto N; Rahayu P; Matsuo M
Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):98-105. PubMed ID: 12971521
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.
Nguyen-Van D; Ernberg I; Phan-Thi Phi P; Tran-Thi C; Hu L
Virus Genes; 2008 Oct; 37(2):273-81. PubMed ID: 18663567
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.
Chen YY; Chang KL; Chen WG; Shibata D; Hayashi K; Weiss LM
Lab Invest; 1998 Jul; 78(7):877-82. PubMed ID: 9690565
[TBL] [Abstract][Full Text] [Related]
34. The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma.
Li DJ; Bei JX; Mai SJ; Xu JF; Chen LZ; Zhang RH; Yu XJ; Hong MH; Zeng YX; Kang T
J Med Virol; 2009 Jul; 81(7):1253-60. PubMed ID: 19475622
[TBL] [Abstract][Full Text] [Related]
35. Latent membrane protein-1 oncogene deletions in nasopharyngeal carcinoma in Caucasian patients.
Plaza G; Santón A; Vidal AM; Bellas C
Acta Otolaryngol; 2003 Jun; 123(5):664-8. PubMed ID: 12875592
[TBL] [Abstract][Full Text] [Related]
36. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.
Gilligan K; Sato H; Rajadurai P; Busson P; Young L; Rickinson A; Tursz T; Raab-Traub N
J Virol; 1990 Oct; 64(10):4948-56. PubMed ID: 2168978
[TBL] [Abstract][Full Text] [Related]
37. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
[TBL] [Abstract][Full Text] [Related]
38. Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients.
Banko A; Lazarevic I; Cupic M; Stevanovic G; Boricic I; Jovanovic T
J Med Virol; 2012 Apr; 84(4):632-42. PubMed ID: 22337303
[TBL] [Abstract][Full Text] [Related]
39. Frequency of a 30-base pair deletion in the latent membrane protein-1 gene in Epstein-Barr virus-associated lymphomas in Japan.
Hirose Y; Masaki Y; Kurose N
Int J Hematol; 2000 Aug; 72(2):210-5. PubMed ID: 11039671
[TBL] [Abstract][Full Text] [Related]
40. [Sequence analysis of the CTL epitopes in transmembrane region of latent membrane protein 2 of Epstein-Barr virus derived from nasopharyngeal carcinoma cells].
Zhang NH; Zhang XS; Li J; Zhang RH; Gao YF; Zeng MS
Ai Zheng; 2006 May; 25(5):566-9. PubMed ID: 16687075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
